1Oltvai Z N, Milliman C L, Korsmeyer S J. Bcl-2 heterodimerizes in vivo with a conserved hemology, Bax, that accelerates programmed cell death[J]. Cell, 1993,74(4):609-619.
2Chresta C M, Masters J R W, Hickman J A. Hypersensitivity of human teticular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax: Bcl-2 ratio[J]. Cancer Res, 1996,56(8):1 834-1 841.
3Krajewska M, Krajewski S, Epstein I J, et al. Immunohistochemical analysis of bcl-2, bax, bcl-x, and mcl-1 expression in prostate Cancer[J]. Am J Pathol,1996,148(5):1 567-1 576.
4Sierra A, Lloveras B, Castellsague X, et al. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma[J]. Int J Cancer, 1995,60(1):54-60.
5Baretton G B, Diebold J, Christoforis G, et al. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas[J]. Cancer, 1996,77(2):255-264.
10Cascinu S Ferro ED, Catalano G. A randomized trial of octreotide vs supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy[J]. Br J Cancer, 1995, 71:97.
